A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
A Prospective Study to Estimate the Incidence of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Infants and Young Children in Sub-Saharan Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Sponsor: Agence de Médecine Préventive, France
A observational or N/A phase clinical study on Malaria, this trial is completed. The trial is conducted by Agence de Médecine Préventive, France and has accumulated 15 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
15 versions recorded-
Feb 2025 — Present [monthly]
Completed
-
Oct 2024 — Feb 2025 [monthly]
Completed
-
Sep 2024 — Oct 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 10 earlier versions
-
Jun 2022 — Feb 2023 [monthly]
Active Not Recruiting
-
Nov 2021 — Jun 2022 [monthly]
Active Not Recruiting
-
May 2021 — Nov 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Jun 2020 [monthly]
Recruiting
Phase: NA → None
-
Jun 2018 — Jun 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
-
Apr 2017 — Dec 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Agence de Médecine Préventive, France
- Clinical Laboratory Services
- GlaxoSmithKline
- Iqvia Pty Ltd
- PATH
- Parexel
- Réseau en Afrique Francophone pour la Télémédecine,
For direct contact, visit the study record on ClinicalTrials.gov .